Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 4 of 4 for “"Hit-to-lead optimization"”.

  1. Antimycobacterial 2-aminoquinazolinones and benzoxazole-based oximes: synthesis, biological evaluation, physicochemical profiling and supramolecular derivatization

    … treatment regimens, drug-drug interactions, drug toxicities, as well as emergence of widespread multi-drug resistance. Therefore, there is an urgent and compelling need to develop new, more effective, safer drugs with novel mechanisms of action, and which are capable of shortening treatment …

    cape-town Repository record for Antimycobacterial 2-aminoquinazolinones and benzoxazole-based oximes: synthesis, biological evaluation, physicochemical profiling and supramolecular derivatization (opens in a new tab)

  2. Computer-Aided Drug Discovery for Helicobacter pylori

    … and is currently the only bacteria considered to be a class I carcinogen and there is a critical need to identify novel chemical matter to treat H. pylori infections. Hp is responsible for greater than 60% of gastric cancer related deaths and 89% of all gastric cancer morbidities. In a previous …

    tenn-hsc Repository record for Computer-Aided Drug Discovery for Helicobacter pylori (opens in a new tab)

  3. INTEGRATION OF QUANTUM-MECHANICAL AND MOLECULAR DOCKING APPROACHES IN GLOBAL METHODS FOR METABOLISM PREDICTION OF XENOBIOTICS

    In silico methods represent a great opportunity to speed up some steps of the drug discovery process. Two in silico strategies that can be useful at different stages of the drug discovery process are presented here: in silico xenobiotic metabolism prediction and QSAR modeling. The former can be …

    milano Repository record for INTEGRATION OF QUANTUM-MECHANICAL AND MOLECULAR DOCKING APPROACHES IN GLOBAL METHODS FOR METABOLISM PREDICTION OF XENOBIOTICS (opens in a new tab)

  4. The Discovery and Development of Thienopyrimidines as Inhibitors of Helicobacter pylori

    … 75%. The triple therapy, which consists of a proton pump inhibitor and two broad-spectrum antibiotics such as clarithromycin and amoxicillin, is becoming less effective due to the rise of strains with resistance against these antibiotics. In the search for narrow spectrum drugs for the treatment …

    tenn-hsc Repository record for The Discovery and Development of Thienopyrimidines as Inhibitors of Helicobacter pylori (opens in a new tab)